- Home
- STEM vs CRBU Comparison
STEM vs CRBU Comparison
Compare STEM & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEM
- CRBU
- Stock Information
- Founded
- STEM 2009
- CRBU 2011
- Country
- STEM United States
- CRBU United States
- Employees
- STEM N/A
- CRBU N/A
- Industry
- STEM Computer Software: Prepackaged Software
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- STEM Technology
- CRBU Health Care
- Exchange
- STEM Nasdaq
- CRBU Nasdaq
- Market Cap
- STEM 104.3M
- CRBU 199.7M
- IPO Year
- STEM N/A
- CRBU 2021
- Fundamental
- Price
- STEM $0.44
- CRBU $1.72
- Analyst Decision
- STEM Hold
- CRBU Strong Buy
- Analyst Count
- STEM 12
- CRBU 4
- Target Price
- STEM $2.71
- CRBU $14.00
- AVG Volume (30 Days)
- STEM 10.1M
- CRBU 970.5K
- Earning Date
- STEM 10-31-2024
- CRBU 08-06-2024
- Dividend Yield
- STEM N/A
- CRBU N/A
- EPS Growth
- STEM N/A
- CRBU N/A
- EPS
- STEM N/A
- CRBU N/A
- Revenue
- STEM $360,632,000.00
- CRBU $33,113,000.00
- Revenue This Year
- STEM N/A
- CRBU N/A
- Revenue Next Year
- STEM $131.69
- CRBU $3.24
- P/E Ratio
- STEM N/A
- CRBU N/A
- Revenue Growth
- STEM N/A
- CRBU 132.34
- 52 Week Low
- STEM $0.44
- CRBU $1.50
- 52 Week High
- STEM $5.15
- CRBU $8.33
- Technical
- Relative Strength Index (RSI)
- STEM 31.95
- CRBU 34.92
- Support Level
- STEM $0.56
- CRBU $2.05
- Resistance Level
- STEM $0.66
- CRBU $2.24
- Average True Range (ATR)
- STEM 0.08
- CRBU 0.15
- MACD
- STEM 0.00
- CRBU -0.04
- Stochastic Oscillator
- STEM 0.60
- CRBU 13.24
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on innovative technology services that transform the way energy is distributed and consumed.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.